ESC 365 - Empagliflozin in acute heart failure with diuretic resistance: Clinical case and rationale for the DRIP-AHF1 trial

ESC Professional Premium Access

Empagliflozin in acute heart failure with diuretic resistance: Clinical case and rationale for the DRIP-AHF1 trial

Session: Heart failure (1)

Topic: Clinical

Speaker: Doctor P. Marques (Montreal, CA)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Pedro Marques

McGill University Health Centre, Montreal (Canada)

1 presentation

0 follower

4 more presentations in this session

Left ventricle outflow tract obstruction in a patient with pheochromocytoma.

Speaker: Doctor J. Aguilar (Mexico City, MX)

"Iron heart": A case of an iron overload cardiomyopathy requiering aetiology related therapy

Speaker: Associate Professor M. Polovina (Belgrade, RS)

A reversible and under-recognized cause of diastolic heart failure

Speaker: Doctor K. Htwe (Flint, US)

Left pulmonary artery hypoplasia: a rare cause of severe left ventricular systolic dysfunction

Speaker: Doctor O. Andrei (Bucharest, RO)

Access the full session

Heart failure (1)

Speakers: Doctor P. Marques, Doctor J. Aguilar, Associate Professor M. Polovina, Doctor K. Htwe, Doctor O. Andrei

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources